Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NTRK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
PLA2R1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IRF6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAPPA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYCN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADAMTS6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDE1C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OR8G1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COL13A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
XIST - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ARHGEF11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AURKC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRLR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on